Cite
HARVARD Citation
Diamond, J. et al. (n.d.). 1194PTranslational endpoints in patients with metastatic microsatellite-stable colorectal cancer (MSS-CRC) treated with durvalumab plus monalizumab (anti-NKG2A). Annals of oncology. p. . [Online].